Perrigo acquires Patheon's Mexican operations for US$34m

Published: 13-May-2015
Drug Delivery Finance Pharmaceutical Dosage Forms

Strengthening its capabilities with the addition of softgel manufacturing technology


Perrigo, currently involved in a takeover battle with Mylan, has bought the Mexican operations of Durham, North Carolina, US-based Patheon for US$34m in cash.

Patheon is the US-based contract drug development and manufacturing services division of DPx Holdings.

Perrigo expects the deal immediately to add to its adjusted pre-share earnings for 2015.

Perrigo Chairman, President and CEO Joseph Papa said: 'Perrigo has long desired to be a prime manufacturer of softgel products and we believe the acquisition of Patheon's Mexican operations serves as an ideal entry point into the space.

'Additionally, and importantly, we believe Perrigo is uniquely positioned to maximize the potential of the business by leveraging our own Mexican operations to drive growth and value for our customers and shareholders.'

Perrigo, headquartered in Ireland, has grown to become the world's largest manufacturer of over-the-counter (OTC) products.

  • Companies:
  • Patheon
  • Perrigo
See more

You may also like

Media

Hikma enters into licensing partnership with Perrigo in MENA

Read more
The partnership will provide significant collaboration opportunity

Trending Articles

  1. Sanofi invests €40m into biopharmaceutical manufacturing at its Lyon Gerland site The pharma giant has expanded its French monoclonal antibody production capabilities, while also dedicating €25m to the development of a second-gen polyclonal antibody
  2. Cleancube multi: Guardtech’s container facilities support NHS aseptic pharmacies Award-winning mobile cleanrooms offer fast, flexible solutions for facility upgrades
  3. Pharmaceutics International bolsters its prefilled syringe production capabilities The aseptic and oral dosage CDMO has invested USD $3.6m into advanced labelling, fill/finish and automated visual inspection technologies at its Hunt Valley site in Maryland, US
  4. Ardena's Oss nanomedicine facility gains full GMP approval from the Dutch Healthcare Authority The pharmaceutical manufacturing facility can produce advanced nanoparticle drug delivery systems, including lipid-based, polymeric and metal oxide nanoparticles
  5. Pfizer gains European Commission approval for haemophilia A and B drug, Hympavzi The subcutaneous therapeutic is the first and only anti-tissue factor pathway inhibitor approved for the treatment of haemophilia A or B, and is available in an auto-injector format

Upcoming event

CPhI India

26–28 November 2024 | Online Conference & Networking | Delhi, India See all

You may also like

Media

Hikma enters into licensing partnership with Perrigo in MENA

The partnership will provide significant collaboration opportunity
You need to be a subscriber to read this article.
Click here to find out more.
Research & Development

Inside Patheon’s new flexible pharmaceutical development facilities

In the pharmaceutical sector, flexible facilities are in demand as new niche therapies replace traditional blockbusters. Patheon’s Tony Pidgeon, Process Technology Director, and Louise Hall, PMP, Senior Director, Pharmaceutical Development Services, describe improvements made at the company’s new sterile PDS Suite at its Greenville (NC, USA) site to meet the new trend
Design & Build

Patheon to invest $45m to support continued growth

Investments by the pharmaceutical solutions provider include facility and equipment expansions in key service areas to meet growing customer demand
Manufacturing

Anticipating the formulation challenges of complex molecules

Patheon's webinar which took place on 28 June, is now available on demand
Manufacturing

Thermo Fisher Scientific to acquire leading CDMO, Patheon

The transaction represents a purchase price of approximately $7.2bn
Manufacturing

Patheon completes sterile expansion at Greenville site

Company invests $26m in sterile Pharmaceutical Development Services suite
Manufacturing

Patheon named Supply Chain Resiliency Partner of the Year

Patheon N.V., a leading global provider of high-quality drug development and delivery solutions to the pharmaceutical and biopharma sectors, has won the “Supply Chain Resiliency Partner of the Year” award by the Global Supply Chain Resiliency Council
Subscribe now